General
Preferred name
GLICLAZIDE
Synonyms
SE1702 ()
S1702 ()
S1702, SE1702 ()
Vitile XL ()
Diamicron MR ()
Diaglyk ()
Zicron PR ()
Nazdol MR ()
Dacadis MR ()
Vamju ()
Bilxona ()
J3.151H ()
S-1702 ()
SE-1702 ()
NSC-758673 ()
SE 1702 ()
Glimicron ()
Glimil ()
Edicil ()
Diamicron ()
Zicron ()
S-852 ()
Ziclaseg ()
P&D ID
PD001261
CAS
21187-98-4
Tags
natural product
drug
available
First approval
1972
Drug indication
Diabetic complication
Drug Status
approved
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
16
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Mcule NIBR MoA Box Subset
MedChem Express Bioactive Compound Library
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
29
Properties
(calculated by RDKit )
Molecular Weight
323.13
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
2
Rotatable Bonds
3
Ring Count
3
Aromatic Ring Count
1
cLogP
1.63
TPSA
78.51
Fraction CSP3
0.53
Chiral centers
2.0
Largest ring
6.0
QED
0.89
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
Membrane Transporter/Ion Channel
Target
Potassium Channel
Member status
member
MOA
K(ATP) Channel Blockers
Therapeutic Class
Hypoglycemic Agents
Source data
